Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.37 |
| ▸ | CSF1R | P07333 | 1/20 | 0.33 |
| ▸ | TDO2 | P48775 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.32 |
| ▸ | MAOB | P27338 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | NOS3 | P29474 | 1/20 | 0.31 |
| ▸ | NOS1 | P29475 | 1/20 | 0.31 |
| ▸ | NOS2 | P35228 | 1/20 | 0.31 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.31 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.30 |
| ▸ | TNKS | O95271 | 1/20 | 0.30 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31355173 | 0.98 | IDO1 (0.36) | IDO1CSF1RTDO2SLC6A4MAOB | |
| SCHEMBL24118930 | 0.82 | CSF1R (0.40) | CSF1RMAOBMEN1CYP2C19KMT2A | |
| SCHEMBL20754205 | 0.81 | AHR (0.46) | CSF1RMEN1CYP2C19KMT2ADYRK1A | |
| SCHEMBL27026408 | 0.81 | LPL (0.38) | IDO1CSF1RTDO2MAOBMEN1 | |
| SCHEMBL32690638 | 0.80 | CSF1R (0.33) | IDO1CSF1R | |
| SCHEMBL5019780 | 0.80 | MEN1 (0.46) | MEN1CYP2C19KMT2A | |
| SCHEMBL21204178 | 0.79 | MEN1 (0.41) | CSF1RMEN1CYP2C19KMT2ADYRK1A | |
| SCHEMBL21339756 | 0.79 | MEN1 (0.43) | CSF1RMEN1CYP2C19KMT2ADYRK1A | |
| SCHEMBL26863064 | 0.79 | MEN1 (0.43) | CSF1RMEN1CYP2C19KMT2ADYRK1A | |
| SCHEMBL22135393 | 0.79 | ALOX5 (0.39) | CSF1RMEN1CYP2C19KMT2ADYRK1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230312627-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL AND DEVICE THEREOF | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2023-10-05 | — | — | US | disclosed |
| US-20230312627-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL AND DEVICE THEREOF | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2023-10-05 | — | — | US | disclosed |
| US-20230240129-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL AND DEVICE THEREOF | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2023-07-27 | — | — | US | disclosed |
| US-20230240129-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL AND DEVICE THEREOF | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2023-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230312627-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL AND DEVICE THEREOF | LEF1, CTCF, DNMT1 | IDO1 2520/4885CSF1R 1878/4885TDO2 3075/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.